Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma: Seattle Saturday, November 9, 2024, 15:00 Hr ...

NEW YORK – Adaptive Biotechnologies announced on Thursday that its blood-based ClonoSeq assay has received expanded coverage from Medicare administrative contractor Palmetto GBA for the detection and ...

西雅图 - Adaptive Biotechnologies Corporation (NASDAQ:ADPT)今日宣布,其clonoSEQ检测获得Medicare承包商Palmetto GBA的扩大覆盖范围,将包括患有套细胞淋巴瘤(MCL)的Medicare患者。这一决定允许对这类患者进行可测量残留病变(MRD)的检测和监测。 MCL是非霍奇金淋巴瘤的一种亚型,在美国每年约有4,000例新病例。

YARMOUTH, Maine – Dr. William Felix has worn many hats throughout his career, including chief medical officer for Medicare DMEPOS and medical director of the Pricing, Data Analysis and Coding division ...

SAINT LOUIS--(BUSINESS WIRE)--#cancer--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today that Medicare contractor Palmetto GBA has ...

NEW YORK – Cofactor Genomics said Friday that its machine learning-based predictive diagnostic assay OncoPrism has received coverage from Medicare administrative contractor Palmetto GBA. The test ...

The best GBA games are getting easier and easier to find and play, thanks to the ever-growing retro line-up of games included in Nintendo Switch Online collections. They're well worth seeking out ...

YARMOUTH, Maine – Dr. William Felix has worn many hats throughout his career, including chief medical officer for Medicare DMEPOS and medical director of the Pricing, Data Analysis and Coding division ...

Mark Massaro: Okay. I also wanted to ask -- it seems like we are waiting for, I think it's Palmetto GBA to finalize the LCD for transplant testing. Do you have any sense for when this might hit?

专注于精准医疗解决方案的CareDx, Inc (NASDAQ: CDNA)获得投资公司H.C. Wainwright重申的中性评级。 该评级是在公司上周投资者日期间分享的2024年第三季度初步财务业绩之后给出的。 CareDx预计2024年第三季度总收入在8200万美元至8300万美元之间，同比增长约23%。这一数字超过了分析师此前7950万美元的预期。 收入增长主要归功于公司的检测服务，预计将 ...

Here are results from Districts 3 and 7.